How should Selank be stored and reconstituted?

Lyophilised Selank stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

What route should I use for Selank?

Selank is delivered by intranasal/subq. The intranasal route is preferred for compounds targeting the central nervous system because it bypasses the BBB via the olfactory pathway. The choice depends on target system and convenience.

What is the standard dosing protocol for Selank?

Conventional Selank dosing is 300 mcg per spray; 2-3 sprays daily daily for 2-4 week courses via intranasal/subq. For healthspan and biological-age use specifically, the cycle pattern is typically 8–12 weeks on followed by a 4 week off-period. Higher doses are studied in advanced protocols but produce diminishing dose-response in the published literature.

How does Selank compare to Epithalon and Thymalin?

Selank (Tuftsin-derived heptapeptide anxiolytic, CNS effect lasts hours; plasma short half-life, 300 mcg per spray; 2-3 sprays daily typical dose) differs from peers in the comparison table above. The principal points of difference relative to Epithalon and Thymalin are mechanism, half-life, and target system. The full comparison is in the table above; specific stack selection depends on which dimension matters for the application.

What is the mechanism of action of Selank?

Modulates GABA-A receptor systems indirectly. Increases serotonin metabolism via enkephalinase inhibition. Influences IL-6, BDNF, and TNF-α. The result is anxiolysis without the sedation, dependence, or motor impairment of benzodiazepines. For healthspan and biological-age applications specifically, the relevant downstream consequence is the cascade from receptor engagement to systemic effect: Modulates GABA-A receptor systems indirectly. The longevity / hallmarks of aging interpretation focuses on the pathway-level detail rather than on any single high-level summary.

Should I cycle Selank?

Standard cycle for Selank is 8–12 weeks of daily for 2-4 week courses 300 mcg per spray; 2-3 sprays daily dosing via intranasal/subq, followed by a 4 week complete off-period. The off-period is calibrated to Selank's CNS effect lasts hours; plasma short half-life and to typical receptor downregulation timelines. Continuous indefinite dosing does not show additional clinical benefit in the published literature and increases cumulative downregulation risk.

Home/ Compounds/ Selank

Selank

Longevity

For users tracking biological age and healthspan-relevant biomarkers, Selank sits within a multi-component longevity framework spanning hallmarks-of-aging from cellular (telomere, senescence, mitochondrial) through integrative (inflammaging, nutrient sensing). A Russian-developed heptapeptide derived from tuftsin — anxiolytic without sedation, supported by clinical trial data in generalised anxiety disorder. Cycle-based dosing over 8-12 weeks with pre-post biomarker tracking is the longevity-research convention.

Longevity / Hallmarks of Aging Applications

InflammagingCellular ReprogrammingTelomere SupportNutrient SensingMitochondrial Biogenesis

Key Takeaways

Longevity lens: Selank maps to specific hallmarks-of-aging endpoints rather than to acute clinical markers.
Mechanism: Modulates GABA-A receptor systems indirectly.
Healthspan biomarkers: epigenetic age, telomere length, inflammatory markers, metabolic flexibility - all tracked across pre-post cycles.
Longevity protocol: cycle-based 300 mcg per spray; 2-3 sprays daily daily for 2-4 week courses dosing; 8-12 week cycles favoured over continuous administration.
Longevity stack partners: Epithalon, Thymalin, NAD+.

Longevity / Hallmarks of Aging Mechanism

Modulates GABA-A receptor systems indirectly. Increases serotonin metabolism via enkephalinase inhibition. Influences IL-6, BDNF, and TNF-α. The result is anxiolysis without the sedation, dependence, or motor impairment of benzodiazepines. Healthspan-relevant interpretation of this mechanism asks which biomarkers move, in which direction, on what timescale. The subsections below cover the hallmark mapping, cellular and transcriptional effects, biomarker tracking, and the cycle structure favoured in longevity-research protocols for Selank.

Healthspan markers and biological age

For users measuring epigenetic age, telomere length, or composite biological-age markers (Horvath, PhenoAge, GrimAge) before and after Selank cycles, the question is whether the intervention measurably moves these markers. Current evidence varies by compound but the framework for evaluation is shared: paired pre-post measurement with appropriate inter-test interval.

Cycle-based versus continuous dosing

Selank's longevity protocol is compatible with either cycle-based or continuous dosing depending on the broader stack. The longevity-research convention favours pulsatile and periodic interventions over indefinite continuous administration, on the principle that hormetic stimulation outperforms sustained agonism for systems-biology-relevant endpoints.

Mapping to the hallmarks of aging

Selank's longevity relevance is best evaluated by mapping its mechanism to the hallmarks-of-aging framework. Modulates GABA-A receptor systems indirectly. Increases serotonin metabolism via enkephalinase inhibition. Influences IL-6, BDNF, and TNF-α. The result is anxiolysis without the sedation, dependence, or motor impairment of benzodiazepines. This places its dominant contribution in the integrative hallmarks (systemic and inflammatory) layer of the framework, with secondary effects on adjacent hallmarks that combine to produce the broader healthspan-relevant phenotype.

Longevity / Hallmarks of Aging Applications

NAD+ Metabolism

For nad+ metabolism as a longevity-relevant endpoint, Selank is typically run in cycle-based protocols with paired pre-post biomarker measurement. Epigenetic age tracking, telomere length, and inflammatory panels are the standard outcome measures.

Nutrient Sensing

Selank's contribution to nutrient sensing as a longevity dimension is incremental rather than dramatic, consistent with the broader picture of healthspan-relevant peptides. The compound is best understood as one layer in a multi-component longevity protocol.

Inflammaging

Inflammaging maps to one of the hallmarks of aging and is one of the dimensions on which Selank is evaluated in the longevity literature. Effect size on biomarkers varies across studies; the consistent finding is direction-of-effect rather than dramatic magnitude.

Hallmarks of Aging

For hallmarks of aging as a longevity-relevant endpoint, Selank is typically run in cycle-based protocols with paired pre-post biomarker measurement. Epigenetic age tracking, telomere length, and inflammatory panels are the standard outcome measures.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	Intranasal	300 mcg per spray; 2-3 sprays daily	8–12 weeks on / 4 weeks off
Conservative starter	Intranasal	180 mcg per spray; 2-3 sprays daily	4–6 weeks initial cycle
Longevity focus	Intranasal	300 mcg per spray; 2-3 sprays daily	Daily for 2-4 week courses
Maintenance phase	Intranasal	210 mcg per spray; 2-3 sprays daily	Ongoing with periodic pauses

Dose timing for Selank is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

Selank stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from longevity researchers.

Selank + Epithalon: Identified by Khavinson in St. Pairs naturally with Selank's mechanism in longevity / hallmarks of aging protocols.
Selank + Thymalin: Influences T-cell maturation and immune function. Pairs naturally with Selank's mechanism in longevity / hallmarks of aging protocols.
Selank + NAD+: Coenzyme for over 500 enzymatic reactions including oxidative phosphorylation, glycolysis, fatty acid β-oxidation, and the citric acid cycle. Pairs naturally with Selank's mechanism in longevity / hallmarks of aging protocols.
Selank + MOTS-c: Translocates to the nucleus under metabolic stress and activates AMPK signalling. Pairs naturally with Selank's mechanism in longevity / hallmarks of aging protocols.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Unapproved (approved in Russia) Research: Russian clinical trials in GAD

Excellent. No reported dependence. Mild nasal irritation possible.

Lens-specific safety considerations for longevity / hallmarks of aging use of Selank: Excellent. No reported dependence. Mild nasal irritation possible. Additional longevity / hallmarks of aging monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

Selank — anxiolytic activity and tuftsin-derived peptides

PMID 16240858

Supporting

Selank in generalised anxiety disorder

PMID 21443549

Selank vs Related Peptides

Compound	Profile	Onset	Best For
Selank	Tuftsin-derived heptapeptide anxiolytic	CNS effect lasts hours; plasma short	Longevity
Epithalon	Pineal-derived tetrapeptide	Very short (minutes)	A pineal-derived tetrapeptide best known for telomerase upregulation and pineal-gland melatonin restoration in long-running rodent and human studies
Thymalin	Thymic polypeptide extract	Variable	A complex of low-molecular-weight thymic polypeptides used in Russian clinical research for decades — immunomodulation, anti-aging, and supportive care in chronic disease
MOTS-c	Mitochondrially-encoded peptide	Hours; tissue-distributed	A 16-amino-acid peptide encoded within mitochondrial DNA — discovered in 2015 and shown to regulate metabolic homeostasis, AMPK signalling, and insulin sensitivity
GHK-Cu	Tripeptide-copper complex	~30 min plasma	A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression

Frequently Asked Questions

How do I know if Selank is working?

Track outcome metrics that match the compound's primary mechanism: epigenetic age (DNA methylation panels), inflammatory markers (hsCRP, IL-6), metabolic flexibility (HbA1c, fasting insulin, HOMA-IR), body composition (DEXA), and subjective markers (sleep depth, recovery, well-being). Paired pre-post measurement around cycles is the standard framework.

Does Selank interact with rapamycin, metformin, or other longevity stacks?

Most peptide compounds are compatible with the standard longevity small-molecule stack (rapamycin, metformin, NAD precursors, senolytics in pulsed protocols). Interactions where present are typically additive rather than competitive. Verify case-specifically with a longevity-informed clinician.

What are the long-term safety considerations?

Long-term safety data for most peptide compounds is limited to a small number of well-studied molecules with multi-decade clinical observation. For most others, the long-term framework relies on mechanism-based risk assessment plus accumulating clinical experience. Cycle-based dosing and periodic re-evaluation are appropriate for compounds without 10+ year human safety data.

When in life should I start Selank?

Most longevity-relevant peptides have evidence bases centred on mid-life and later. Earlier use is theoretically reasonable for users with documented age-related markers (elevated inflammation, accelerated epigenetic age) or for compounds whose mechanism is preventative. Below age 35 the benefit for most longevity peptides is theoretical and warrants compound-specific consideration.

How long until I see results from Selank?

Acute effects from Selank appear within hours of dosing for receptor-level changes. healthspan and biological-age endpoints accumulate across 4–8 weeks; the typical 8–12 week cycle is calibrated to allow the full response window. Single-week evaluations consistently underestimate the response trajectory.

Is Selank safe during pregnancy or breastfeeding?

Selank, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

Clinical Protocol

Start a Selank Protocol

Alukard provides physician-supervised longevity protocols with GMP-certified Selank and GMP-certified compounds with biological age testing and healthspan markers.

Get Protocol

Quick Facts

Molecular weight: 751 Da
Sequence length: 7 aa
Half-life: CNS effect lasts hours; plasma short
WADA: Not on prohibited list
FDA: Unapproved (approved in Russia)
Research: Russian clinical trials in GAD

Stack Partners

Epithalon

Thymalin

NAD+

MOTS-c

GHK-Cu

Research Note

All longevity / hallmarks of aging applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Selank unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised longevity protocols

Start Your Longevity / Hallmarks of Aging Protocol for Selank

Alukard provides physician-supervised longevity protocols with GMP-certified compounds with biological age testing and healthspan markers.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised